VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 59 filers reported holding VOR BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $773 | -42.5% | 250 | 0.0% | 0.00% | – |
| Q1 2023 | $1,345 | -19.1% | 250 | 0.0% | 0.00% | – |
| Q4 2022 | $1,663 | +66.3% | 250 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 250 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 250 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,692,429 | $288,444,000 | 51.94% |
| Trustees of Columbia University in the City of New York | 183,821 | $7,923,000 | 9.60% |
| RA Capital Management | 11,120,973 | $479,314,000 | 7.23% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $46,318,000 | 6.00% |
| Sarissa Capital Management LP | 707,010 | $30,472,000 | 2.92% |
| SECTORAL ASSET MANAGEMENT INC | 535,259 | $23,070,000 | 1.75% |
| Woodline Partners LP | 1,153,267 | $49,706,000 | 1.10% |
| Artal Group S.A. | 550,000 | $23,705,000 | 0.42% |
| Orbimed Advisors | 833,333 | $35,917,000 | 0.34% |
| Laurion Capital Management LP | 585,667 | $25,242,000 | 0.14% |